speb/financial-data huggingface dataset:
MRD.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1224000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 514762000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Net Income: 14093000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 14093000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 14093000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 14093000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 14093000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 14093000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 14093000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -6456000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Net Investment Properties Purchase And Sale: 12229000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -8416000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -8416000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -6456000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 10895000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -183000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1245849000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 90864000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 90864000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 30051000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 16544511.34
MRD.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -4853000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 6289000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Operating Income: 29793000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 51629000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 30110046.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 31025000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 6195000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -3458000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 355000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 53962000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Payables: 63257000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 63257000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 19879000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment Properties: -1124000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -203000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 138590000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 36555000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 463000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -18255000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1224000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 0.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1139786000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment Properties: 13353000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 20000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 6195000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 30110046.00
MRD.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 10000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 293000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1245849000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1245849000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1006488.66
MRD.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 5786000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.29
MRD.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 4370000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 2059320000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1839780000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 593931000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1245849000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 42750000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 813471000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1055323000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 750214000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 23504000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 1312000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1282000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -3458000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -3458000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 940740000.00
MRD.TO income_statement (annual, 2025-12-31) — +Operating Expense: 29378000.00
MRD.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 8778000.00
MRD.TO income_statement (annual, 2025-12-31) — +Total Revenue: 410547000.00
MRD.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 187122000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 19506000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 19506000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 212812000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 212812000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4844000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4844000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 75160000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 75160000.00
MRD.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 30199875.00
MRD.TO income_statement (annual, 2025-12-31) — Basic EPS: 1.92
MRD.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 54338000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 79169000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 3892000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 3892000.00
MRD.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -668000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -11000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 69697000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 69697000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 74884000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 74884000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 74884000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 74884000.00
MRD.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -14486000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -3916000.00
MRD.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -157278000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -49699000.00
MRD.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 85205000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 26117000.00
MRD.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 93568000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 20103000.00
MRD.TO cash_flow (annual, 2025-12-31) — Change In Inventory: 21233000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 57056000.00
MRD.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 5278000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -8242000.00
MRD.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -41493000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -73873000.00
MRD.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -14982000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -25059000.00
MRD.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -41493000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -73873000.00
MRD.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 21495000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -3479000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Common Stock: 69697000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 69697000.00
MRD.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -14486000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -3916000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1268073000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1268073000.00
MRD.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -76575000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -73115000.00
MRD.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 220900000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 115815000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Current Assets: 1080012000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 1080012000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 55153000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 55153000.00
MRD.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 18911000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -4699000.00
MRD.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 18911000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -4699000.00
MRD.TO cash_flow (annual, 2025-12-31) — Depreciation: 1156000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 156000.00
MRD.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1156000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 156000.00
MRD.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 226000.00
MRD.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1156000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 156000.00
MRD.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 226000.00
MRD.TO income_statement (annual, 2025-12-31) — Depreciation Income Statement: 226000.00
MRD.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 30433788.00
MRD.TO income_statement (annual, 2025-12-31) — Diluted EPS: 1.91
MRD.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 58019000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 31652000.00
MRD.TO income_statement (annual, 2025-12-31) — EBIT: 129634000.00
MRD.TO income_statement (quarterly, 2025-12-31) — EBIT: 44302000.00
MRD.TO income_statement (annual, 2025-12-31) — EBITDA: 130790000.00
MRD.TO income_statement (quarterly, 2025-12-31) — EBITDA: 44458000.00
MRD.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -949000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -806000.00
MRD.TO cash_flow (annual, 2025-12-31) — End Cash Position: 74884000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 74884000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Financial Assets: 1687000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Financial Assets: 1687000.00
MRD.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -157278000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -49699000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 716615000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 716615000.00
MRD.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 92900000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 20092000.00
MRD.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 25878000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 20596000.00
MRD.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 126000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 0.00
MRD.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -21779000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -19654000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 26969000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 26969000.00
MRD.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 27840000.00
MRD.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 7240000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 10750000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 10750000.00
MRD.TO income_statement (annual, 2025-12-31) — Gross Profit: 189647000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 71307000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 2884000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 2884000.00
MRD.TO income_statement (annual, 2025-12-31) — Interest Expense: 23292000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 5635000.00
MRD.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 23292000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 5635000.00
MRD.TO income_statement (annual, 2025-12-31) — Interest Income: 4415000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Interest Income: 1528000.00
MRD.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 4415000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1528000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Inventory: 716615000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 716615000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 1816817000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1816817000.00
MRD.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: 85205000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 26117000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Investment Properties: 907793000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Investment Properties: 907793000.00
MRD.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 33236000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -12300000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 1293000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 1293000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 548744000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 548744000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 548744000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 548744000.00
MRD.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 33236000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -12300000.00
MRD.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -93575000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -31665000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 92930000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 92930000.00
MRD.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -76575000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -73115000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Net Debt: 473860000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 473860000.00
MRD.TO income_statement (annual, 2025-12-31) — Net Income: 58019000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Net Income: 31652000.00
MRD.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 58019000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 31652000.00
MRD.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 58019000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 31652000.00
MRD.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 58019000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 31652000.00
MRD.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 58019000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 31652000.00
MRD.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 58019000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 31652000.00
MRD.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 58019000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 31652000.00
MRD.TO income_statement (annual, 2025-12-31) — Net Interest Income: -23156000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -4208000.00
MRD.TO cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: 7394000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Net Investment Properties Purchase And Sale: -774000.00
MRD.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 3773000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
MRD.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -60339000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -43965000.00
MRD.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -60339000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -43965000.00
MRD.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -23156000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -4208000.00
MRD.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -5878000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 71297000.00
MRD.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 74706000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 27078000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Net PPE: 10750000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 10750000.00
MRD.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -668000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -187000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1268073000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1268073000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 86235000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 86235000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 86235000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 86235000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 6562000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 6562000.00
MRD.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 152443000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 64112000.00
MRD.TO income_statement (annual, 2025-12-31) — Normalized Income: 76424050.00
MRD.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 47740354.62
MRD.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 93568000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 20103000.00
MRD.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 25752000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 20596000.00
MRD.TO income_statement (annual, 2025-12-31) — Operating Income: 160269000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Operating Income: 62529000.00
MRD.TO income_statement (annual, 2025-12-31) — Operating Revenue: 319349000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 162958000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 30102605.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 30102605.00
MRD.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 26969000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 26969000.00
MRD.TO income_statement (annual, 2025-12-31) — Other Gand A: 10037000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Other Gand A: -10563000.00
MRD.TO income_statement (annual, 2025-12-31) — Other Income Expense: -30771000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -19654000.00
MRD.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3382000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -2908000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 44331000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 44331000.00
MRD.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -9118000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 0.00
MRD.TO balance_sheet (annual, 2025-12-31) — Other Payable: 32763000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 32763000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Other Properties: 5565000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 5565000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 0.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 0.00
MRD.TO balance_sheet (annual, 2025-12-31) — Payables: 55153000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Payables: 55153000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 55153000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 55153000.00
MRD.TO income_statement (annual, 2025-12-31) — Pretax Income: 106342000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 38667000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MRD.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
MRD.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment Properties: -8346000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment Properties: -1128000.00
MRD.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -668000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -11000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Receivables: 213353000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 213353000.00
MRD.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 219970000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 115815000.00
MRD.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1156000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 156000.00
MRD.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -93575000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -31665000.00
MRD.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -76575000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -73115000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Restricted Cash: 0.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 0.00
MRD.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 1166563000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1166563000.00
MRD.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 17803000.00
MRD.TO cash_flow (annual, 2025-12-31) — Sale Of Investment: 3773000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
MRD.TO cash_flow (annual, 2025-12-31) — Sale Of Investment Properties: 15740000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Sale Of Investment Properties: 354000.00
MRD.TO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 1312000.00
MRD.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 29152000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 8552000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Share Issued: 30102605.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 30102605.00
MRD.TO income_statement (annual, 2025-12-31) — Special Income Charges: 126000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
MRD.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1330000.00
MRD.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 365000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1268073000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1268073000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1268073000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1268073000.00
MRD.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3247950.00
MRD.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -3565645.38
MRD.TO income_statement (annual, 2025-12-31) — Tax Provision: 48323000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 7015000.00
MRD.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
MRD.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.18
MRD.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 541000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 541000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Total Assets: 2051135000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 2051135000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 1816817000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1816817000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Total Debt: 548744000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 548744000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1268073000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1268073000.00
MRD.TO income_statement (annual, 2025-12-31) — Total Expenses: 250278000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 124593000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 783062000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 783062000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 971123000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 971123000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 727909000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 727909000.00
MRD.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 125399000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 41933000.00
MRD.TO income_statement (annual, 2025-12-31) — Total Other Finance Cost: 4279000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 101000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 2884000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 2884000.00
MRD.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -21653000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -19654000.00
MRD.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -21653000.00
MRD.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -19654000.00
MRD.TO balance_sheet (annual, 2025-12-31) — Working Capital: 1024859000.00
MRD.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 1024859000.00
MRD.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 6122000.00
MRD.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 45365000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 46235000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 198425000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 5112000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 30360000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 30094805.00
MRD.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.77
MRD.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 80549000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -39000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 69534000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 54482000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 54482000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -15024000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -55343000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 43264000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -14635000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -15250000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -17273000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 9940000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -22583000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 9940000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -26714000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 69534000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -15024000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1278571000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1091000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 23530000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 1003458000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 46235000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -13923000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: -13923000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 275000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 275000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 275000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 30490789.00
MRD.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.76
MRD.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 23173000.00
MRD.TO income_statement (quarterly, 2026-03-31) — EBIT: 18213000.00
MRD.TO income_statement (quarterly, 2026-03-31) — EBITDA: 18488000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 647000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 54482000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Financial Assets: 1701000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -55343000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 718924000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -14674000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -1026000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 2043000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 1033000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 30162000.00
MRD.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 6122000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 21835000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 4764000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 0.00
MRD.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 4832000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 4832000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Interest Income: 1087000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1087000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 7300000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 718924000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1780116000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 43264000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Investment Properties: 911564000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 788000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 501545000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 501545000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 788000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -40016000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 78168000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1091000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 447063000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Net Income: 23173000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 23173000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 23173000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 23173000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 23173000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 23173000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 23173000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -5408000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Net Investment Properties Purchase And Sale: 220000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 0.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -39228000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -39228000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -5408000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 43080000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 10513000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -36000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1278571000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 72312000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 72312000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 15412000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 21327400.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -14635000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -3069000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Operating Income: 15713000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 20813000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 30036833.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 30162000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 6122000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 3076000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1224000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 49595000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Payables: 46235000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 46235000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 13381000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment Properties: -652000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -39000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 199692000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 23530000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 275000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -40016000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1091000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1173763000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 0.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Sale Of Investment Properties: 872000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 3000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 6122000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 30036833.00
MRD.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: 2043000.00
MRD.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 268000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1278571000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1278571000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 1230400.00
MRD.TO income_statement (quarterly, 2026-03-31) — Tax Provision: -9792000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
MRD.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1267000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 1976831000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1780116000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 501545000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1278571000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 29652000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 698260000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 973373000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 652025000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 18782000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 1663000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
MRD.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 3076000.00
MRD.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 3076000.00
MRD.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 957223000.00
MRDN balance_sheet (annual, 2021-10-31) — Accumulated Depreciation: 0.00
MRDN balance_sheet (annual, 2021-10-31) — Current Accrued Expenses: 123.00
MRDN balance_sheet (annual, 2021-10-31) — Current Deferred Taxes Liabilities: 0.00
MRDN balance_sheet (annual, 2021-10-31) — Interest Payable: 123.00
MRDN balance_sheet (annual, 2021-10-31) — Restricted Cash: 61799.00
MRDN balance_sheet (annual, 2022-10-31) — Accumulated Depreciation: -32378.00
MRDN cash_flow (annual, 2022-10-31) — Asset Impairment Charge: 0.00
MRDN balance_sheet (annual, 2022-10-31) — Cash Financial: 14949673.00
MRDN cash_flow (annual, 2022-10-31) — Change In Accrued Expense: 0.00
MRDN cash_flow (annual, 2022-10-31) — Change In Interest Payable: 0.00
MRDN cash_flow (annual, 2022-10-31) — Common Stock Issuance: 0.00
MRDN balance_sheet (annual, 2022-10-31) — Current Accrued Expenses: 123.00
MRDN balance_sheet (annual, 2022-10-31) — Current Deferred Taxes Liabilities: 4409.00
MRDN balance_sheet (annual, 2022-10-31) — Goodwill: 10452324.00
MRDN balance_sheet (annual, 2022-10-31) — Interest Payable: 123.00
MRDN cash_flow (annual, 2022-10-31) — Issuance Of Capital Stock: 0.00
MRDN balance_sheet (annual, 2022-10-31) — Long Term Debt And Capital Lease Obligation: 59778.00
MRDN cash_flow (annual, 2022-10-31) — Long Term Debt Payments: 0.00
MRDN cash_flow (annual, 2022-10-31) — Net Foreign Currency Exchange Gain Loss: -110053.00
MRDN cash_flow (annual, 2022-10-31) — Net Issuance Payments Of Debt: 0.00
MRDN cash_flow (annual, 2022-10-31) — Net Long Term Debt Issuance: 0.00
MRDN cash_flow (annual, 2022-10-31) — Operating Gains Losses: -110053.00
MRDN cash_flow (annual, 2022-10-31) — Other Non Cash Items: 6000.00
MRDN cash_flow (annual, 2022-10-31) — Repayment Of Debt: 0.00
MRDN income_statement (annual, 2022-10-31) — Research And Development: 23092.00
MRDN balance_sheet (annual, 2022-10-31) — Restricted Cash: 52577.00
MRDN cash_flow (annual, 2022-10-31) — Sale Of Business: 0.00
MRDN income_statement (annual, 2022-10-31) — Special Income Charges: 0.00
MRDN income_statement (annual, 2022-10-31) — Write Off: 0.00
MRDN income_statement (annual, 2023-10-31) — +Operating Expense: 10395118.00
MRDN income_statement (annual, 2023-10-31) — +Total Revenue: 44174052.00
MRDN balance_sheet (annual, 2023-10-31) — Accounts Payable: 2847653.00
MRDN balance_sheet (annual, 2023-10-31) — Accounts Receivable: 3551383.00
MRDN balance_sheet (annual, 2023-10-31) — Accumulated Depreciation: -73672.00
MRDN balance_sheet (annual, 2023-10-31) — Additional Paid In Capital: 57023788.00
MRDN balance_sheet (annual, 2023-10-31) — Allowance For Doubtful Accounts Receivable: 0.00
MRDN cash_flow (annual, 2023-10-31) — Amortization Cash Flow: 439933.00
MRDN cash_flow (annual, 2023-10-31) — Amortization Of Intangibles: 439933.00
MRDN income_statement (annual, 2023-10-31) — Basic Average Shares: 2951724.00
MRDN income_statement (annual, 2023-10-31) — Basic EPS: -0.36
MRDN cash_flow (annual, 2023-10-31) — Beginning Cash Position: 14949673.00
MRDN cash_flow (annual, 2023-10-31) — Capital Expenditure: -65253.00
MRDN balance_sheet (annual, 2023-10-31) — Capital Lease Obligations: 59089.00
MRDN balance_sheet (annual, 2023-10-31) — Capital Stock: 362.00
MRDN balance_sheet (annual, 2023-10-31) — Cash And Cash Equivalents: 17100280.00
MRDN balance_sheet (annual, 2023-10-31) — Cash Cash Equivalents And Short Term Investments: 17100280.00
MRDN balance_sheet (annual, 2023-10-31) — Cash Financial: 17100280.00
MRDN cash_flow (annual, 2023-10-31) — Cash Flow From Continuing Financing Activities: -32322.00
MRDN cash_flow (annual, 2023-10-31) — Cash Flow From Continuing Investing Activities: -95961.00
MRDN cash_flow (annual, 2023-10-31) — Cash Flow From Continuing Operating Activities: 2206367.00
MRDN cash_flow (annual, 2023-10-31) — Change In Account Payable: 3668826.00
MRDN cash_flow (annual, 2023-10-31) — Change In Income Tax Payable: 137150.00
MRDN cash_flow (annual, 2023-10-31) — Change In Inventory: -514860.00
MRDN cash_flow (annual, 2023-10-31) — Change In Other Current Assets: 96820.00
MRDN cash_flow (annual, 2023-10-31) — Change In Other Current Liabilities: -98619.00
MRDN cash_flow (annual, 2023-10-31) — Change In Other Working Capital: 178198.00
MRDN cash_flow (annual, 2023-10-31) — Change In Payable: 3805976.00
MRDN cash_flow (annual, 2023-10-31) — Change In Payables And Accrued Expense: 3805976.00
MRDN cash_flow (annual, 2023-10-31) — Change In Prepaid Assets: -16958.00
MRDN cash_flow (annual, 2023-10-31) — Change In Receivables: -3037174.00
MRDN cash_flow (annual, 2023-10-31) — Change In Tax Payable: 137150.00
MRDN cash_flow (annual, 2023-10-31) — Change In Working Capital: 413383.00
MRDN cash_flow (annual, 2023-10-31) — Changes In Account Receivables: -3037174.00
MRDN cash_flow (annual, 2023-10-31) — Changes In Cash: 2078084.00
MRDN balance_sheet (annual, 2023-10-31) — Common Stock: 362.00
MRDN balance_sheet (annual, 2023-10-31) — Common Stock Equity: 31103394.00
MRDN cash_flow (annual, 2023-10-31) — Common Stock Payments: -32322.00
MRDN income_statement (annual, 2023-10-31) — Cost Of Revenue: 34305181.00
MRDN balance_sheet (annual, 2023-10-31) — Current Accrued Expenses: 123.00
MRDN balance_sheet (annual, 2023-10-31) — Current Assets: 22852676.00
MRDN balance_sheet (annual, 2023-10-31) — Current Capital Lease Obligation: 59089.00
MRDN balance_sheet (annual, 2023-10-31) — Current Debt And Capital Lease Obligation: 59089.00
MRDN balance_sheet (annual, 2023-10-31) — Current Deferred Liabilities: 475545.00
MRDN balance_sheet (annual, 2023-10-31) — Current Deferred Revenue: 456726.00
MRDN balance_sheet (annual, 2023-10-31) — Current Deferred Taxes Liabilities: 18819.00
MRDN balance_sheet (annual, 2023-10-31) — Current Liabilities: 4479423.00
MRDN cash_flow (annual, 2023-10-31) — Depreciation: 41380.00
MRDN cash_flow (annual, 2023-10-31) — Depreciation Amortization Depletion: 481313.00
MRDN cash_flow (annual, 2023-10-31) — Depreciation And Amortization: 481313.00
MRDN income_statement (annual, 2023-10-31) — Diluted Average Shares: 2951724.00
MRDN income_statement (annual, 2023-10-31) — Diluted EPS: -0.36
MRDN income_statement (annual, 2023-10-31) — Diluted NI Availto Com Stockholders: -1172750.00
MRDN balance_sheet (annual, 2023-10-31) — Duefrom Related Parties Current: 331246.00
MRDN balance_sheet (annual, 2023-10-31) — Dueto Related Parties Current: 12921.00
MRDN income_statement (annual, 2023-10-31) — EBIT: -477044.00
MRDN income_statement (annual, 2023-10-31) — EBITDA: 4269.00
MRDN cash_flow (annual, 2023-10-31) — Effect Of Exchange Rate Changes: 72523.00
MRDN cash_flow (annual, 2023-10-31) — End Cash Position: 17100280.00
MRDN cash_flow (annual, 2023-10-31) — Financing Cash Flow: -32322.00